Abstract Details

Title Fremanezumab Decreases Migraine Symptoms such as Nausea, Vomiting, Photophobia and Phonophobia and Reduces the Need for Acute Medications in the First Week of Treatment in the HFEM Study

Topic Headache

Presentation(s) P4 - (-)

Poster/Presentation
Number 111

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Marcelo E. Bigal, MD, PhD (Purdue) PRESENTER	No disclosure on file
	No disclosure on file
Ernesto Aycardi, MD (Kyowa Kirin)	Dr. Aycardi has received personal compensation for serving as an employee of XENON. Dr. Aycardi has received stock or an ownership interest from XENON.
Pippa S. Loupe, PhD	No disclosure on file
Robert Noble	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��